Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2026 Filed Oct 9, 2026 20:02 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 2,676 | $44.88 | $120,098.88 |
DisclosureSEC source: 0001193125-26-419058 · ownership.xml · nonDerivative · entry 5 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,571 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.82 - $45.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 20:02 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 45,085 | $44.33 | $1,998,618.05 |
DisclosureSEC source: 0001193125-26-419058 · ownership.xml · nonDerivative · entry 4 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,247 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.82 - $44.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 07, 2026 Filed Oct 9, 2026 20:02 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 494 | $46.43 | $22,936.42 |
DisclosureSEC source: 0001193125-26-419058 · ownership.xml · nonDerivative · entry 3 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,332 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.38 - $46.46, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 07, 2026 Filed Oct 9, 2026 20:02 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 5,331 | $45.68 | $243,520.08 |
DisclosureSEC source: 0001193125-26-419058 · ownership.xml · nonDerivative · entry 2 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.35 - $46.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 07, 2026 Filed Oct 9, 2026 20:02 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 43,692 | $44.90 | $1,961,770.80 |
DisclosureSEC source: 0001193125-26-419058 · ownership.xml · nonDerivative · entry 1 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,157 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.35 - $45.34, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:10 UTC |
Alving Amy EDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397920 · ownership.xml · derivative · entry 1 Alving Amy E · CIK 0001490905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:09 UTC |
CLARK KEVIN PDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397918 · ownership.xml · derivative · entry 1 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:08 UTC |
Vinci SharonChief People Officer
|
GrantDividend Equivalent Rights · Derivative | 172.634 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397914 · ownership.xml · derivative · entry 1 Vinci Sharon · CIK 0002055680 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172.634 Underlying: Ordinary Shares · 172.634 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:07 UTC |
CELIAN JASONChief Accounting Officer
|
GrantDividend Equivalent Rights · Derivative | 25.753 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397910 · ownership.xml · derivative · entry 1 CELIAN JASON · CIK 0002124148 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.753 Underlying: Ordinary Shares · 25.753 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:07 UTC |
Ostermann Douglas RChief Financial Officer
|
GrantDividend Equivalent Rights · Derivative | 480.603 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397905 · ownership.xml · derivative · entry 1 Ostermann Douglas R · CIK 0001538560 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480.603 Underlying: Ordinary Shares · 480.603 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:06 UTC |
Liotine Joseph T.Director · CEO and Director
|
GrantDividend Equivalent Rights · Derivative | 489.229 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397902 · ownership.xml · derivative · entry 1 Liotine Joseph T. · CIK 0001624146 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489.229 Underlying: Ordinary Shares · 489.229 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:05 UTC |
Cerepak Brad MDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397894 · ownership.xml · derivative · entry 1 Cerepak Brad M · CIK 0001333585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:04 UTC |
Kueppers EricDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397888 · ownership.xml · derivative · entry 1 Kueppers Eric · CIK 0002104341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:03 UTC |
Tamez ArmandoDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397884 · ownership.xml · derivative · entry 1 Tamez Armando · CIK 0002100428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:03 UTC |
MEISTER PAUL MDirector
|
GrantDividend Equivalent Rights · Derivative | 14.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397877 · ownership.xml · derivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.65 Underlying: Ordinary Shares · 14.65 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:02 UTC |
Acosta Janis NCLO and Secretary
|
GrantDividend Equivalent Rights · Derivative | 113.023 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-397871 · ownership.xml · derivative · entry 1 Acosta Janis N · CIK 0001806926 · CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113.023 Underlying: Ordinary Shares · 113.023 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.exercise_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. F1 · derivative.expiration_date: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 105 | $47.08 | $4,943.40 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 6 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,849 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F7 · price: All shares were sold at $47.08. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 16,517 | $46.27 | $764,241.59 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 5 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,954 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.99 to $46.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 57,508 | $45.49 | $2,616,038.92 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 4 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,471 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.99 to $45.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 1,287 | $49.67 | $63,925.29 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 3 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,979 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.40 to $50.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 9,034 | $48.50 | $438,149.00 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 2 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,266 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.30 to $49.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:49 UTC |
CLARK KEVIN PDirector
|
SaleOrdinary Shares | 38,271 | $47.85 | $1,831,267.35 |
DisclosureSEC source: 0001193125-26-388150 · ownership.xml · nonDerivative · entry 1 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.30 to $48.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| June 21, 2026 Filed Jun 23, 2026 20:01 UTC |
Liotine Joseph T.Director · CEO and Director
|
Tax withholdingOrdinary Shares | 21,289 | $45.89 | $976,952.21 |
DisclosureSEC source: 0001193125-26-279414 · ownership.xml · nonDerivative · entry 1 Liotine Joseph T. · CIK 0001624146 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,864 F1 · price: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:06 UTC |
MEISTER PAUL MDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177156 · ownership.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,561 F1 · balance_after: On April 1, 2026, Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv on a pro rata basis (the "Distribution"). This amount includes 6,393 Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:14 UTC |
CLARK KEVIN PDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177274 · ownership.xml · nonDerivative · entry 1 CLARK KEVIN P · CIK 0001248750 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,571 F1 · balance_after: On April 1, 2026, Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv on a pro rata basis (the "Distribution"). This amount includes 242,403 Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:13 UTC |
Vinci SharonChief People Officer
|
GrantOrdinary Shares | 18,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177270 · ownership.xml · nonDerivative · entry 1 Vinci Sharon · CIK 0002055680 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,474 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:13 UTC |
Acosta Janis NCLO and Secretary
|
GrantOrdinary Shares | 21,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177269 · ownership.xml · nonDerivative · entry 2 Acosta Janis N · CIK 0001806926 · CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,871 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:13 UTC |
Acosta Janis NCLO and Secretary
|
GrantOrdinary Shares | 18,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177269 · ownership.xml · nonDerivative · entry 1 Acosta Janis N · CIK 0001806926 · CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,617 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:12 UTC |
CELIAN JASONChief Accounting Officer
|
GrantOrdinary Shares | 6,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177265 · ownership.xml · nonDerivative · entry 1 CELIAN JASON · CIK 0002124148 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,335 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:11 UTC |
Ostermann Douglas RChief Financial Officer
|
GrantOrdinary Shares | 43,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177261 · ownership.xml · nonDerivative · entry 1 Ostermann Douglas R · CIK 0001538560 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,542 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:10 UTC |
Liotine Joseph T.Director · CEO and Director
|
GrantOrdinary Shares | 111,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177256 · ownership.xml · nonDerivative · entry 1 Liotine Joseph T. · CIK 0001624146 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,153 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:10 UTC |
Cerepak Brad MDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177248 · ownership.xml · nonDerivative · entry 1 Cerepak Brad M · CIK 0001333585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,168 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:09 UTC |
Kueppers EricDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177186 · ownership.xml · nonDerivative · entry 1 Kueppers Eric · CIK 0002104341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,168 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
Tamez ArmandoDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177168 · ownership.xml · nonDerivative · entry 1 Tamez Armando · CIK 0002100428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,168 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:06 UTC |
Alving Amy EDirector
|
GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-177160 · ownership.xml · nonDerivative · entry 1 Alving Amy E · CIK 0001490905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,168 Read SEC document |
| April 02, 2026 Filed Apr 7, 2026 01:06 UTC |
Vinci SharonChief People Officer
|
GrantOrdinary shares, par value $0.01 per share | 42,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-005405 · ownership.xml · nonDerivative · entry 1 Vinci Sharon · CIK 0002055680 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,857 F1 · date: On April 1, 2026 (the "Distribution Date"), Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv ("Aptiv Ordinary Shares") on a pro rata basis (the "Distribution"). F2 · date: Under the Employee Matters Agreement, dated March 30, 2026, between Aptiv and Issuer, and the Aptiv Long-Term Incentive Plan (the "LTIP"), each restricted stock unit award with respect to Aptiv Ordinary Shares granted by Aptiv under the LTIP prior to the Distribution Date (each, an "Aptiv RSU Award") was equitably adjusted and converted into a restricted stock unit award with respect to Issuer Ordinary Shares (each, an "Issuer RSU Award"), based on (I) the number of Aptiv Ordinary Shares underlying the Aptiv RSU Award immediately prior to the Distribution and (II) a fraction, the numerator of which is (A) the closing price of an Aptiv Ordinary Share on the New York Stock Exchange ("NYSE") on the trading day immediately after the Distribution Date, and (B) the denominator of which is the two-day volume-weighted average price of an Issuer Ordinary Share on the NYSE during the first and second trading days immediately after the Distribution (the "Award Conversion"). F3 · shares: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F3 · price: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F4 · balance_after: This amount includes Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 02, 2026 Filed Apr 7, 2026 01:04 UTC |
Ostermann Douglas RChief Financial Officer
|
GrantOrdinary shares, par value $0.01 per share | 126,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-005404 · ownership.xml · nonDerivative · entry 1 Ostermann Douglas R · CIK 0001538560 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,104 F1 · date: On April 1, 2026 (the "Distribution Date"), Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv ("Aptiv Ordinary Shares") on a pro rata basis (the "Distribution"). F2 · date: Under the Employee Matters Agreement, dated March 30, 2026, between Aptiv and Issuer, and the Aptiv Long-Term Incentive Plan (the "LTIP"), each restricted stock unit award with respect to Aptiv Ordinary Shares granted by Aptiv under the LTIP prior to the Distribution Date (each, an "Aptiv RSU Award") was equitably adjusted and converted into a restricted stock unit award with respect to Issuer Ordinary Shares (each, an "Issuer RSU Award"), based on (I) the number of Aptiv Ordinary Shares underlying the Aptiv RSU Award immediately prior to the Distribution and (II) a fraction, the numerator of which is (A) the closing price of an Aptiv Ordinary Share on the New York Stock Exchange ("NYSE") on the trading day immediately after the Distribution Date, and (B) the denominator of which is the two-day volume-weighted average price of an Issuer Ordinary Share on the NYSE during the first and second trading days immediately after the Distribution (the "Award Conversion"). F3 · shares: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F3 · price: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F4 · balance_after: This amount includes Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 02, 2026 Filed Apr 7, 2026 01:04 UTC |
CELIAN JASONChief Accounting Officer
|
GrantOrdinary shares, par value $0.01 per share | 2,103 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-005403 · ownership.xml · nonDerivative · entry 1 CELIAN JASON · CIK 0002124148 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,353 F1 · date: On April 1, 2026 (the "Distribution Date"), Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv ("Aptiv Ordinary Shares") on a pro rata basis (the "Distribution"). F2 · date: Under the Employee Matters Agreement, dated March 30, 2026, between Aptiv and Issuer, and the Aptiv Long-Term Incentive Plan (the "LTIP"), each restricted stock unit award with respect to Aptiv Ordinary Shares granted by Aptiv under the LTIP prior to the Distribution Date (each, an "Aptiv RSU Award") was equitably adjusted and converted into a restricted stock unit award with respect to Issuer Ordinary Shares (each, an "Issuer RSU Award"), based on (I) the number of Aptiv Ordinary Shares underlying the Aptiv RSU Award immediately prior to the Distribution and (II) a fraction, the numerator of which is (A) the closing price of an Aptiv Ordinary Share on the New York Stock Exchange ("NYSE") on the trading day immediately after the Distribution Date, and (B) the denominator of which is the two-day volume-weighted average price of an Issuer Ordinary Share on the NYSE during the first and second trading days immediately after the Distribution (the "Award Conversion"). F3 · shares: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F3 · price: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F4 · balance_after: This amount includes Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 02, 2026 Filed Apr 7, 2026 01:02 UTC |
Liotine Joseph T.Director · Chief Executive Officer
|
GrantOrdinary shares, par value $0.01 per share | 109,714 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-005402 · ownership.xml · nonDerivative · entry 1 Liotine Joseph T. · CIK 0001624146 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,455 F1 · date: On April 1, 2026 (the "Distribution Date"), Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv ("Aptiv Ordinary Shares") on a pro rata basis (the "Distribution"). F2 · date: Under the Employee Matters Agreement, dated March 30, 2026, between Aptiv and Issuer, and the Aptiv Long-Term Incentive Plan (the "LTIP"), each restricted stock unit award with respect to Aptiv Ordinary Shares granted by Aptiv under the LTIP prior to the Distribution Date (each, an "Aptiv RSU Award") was equitably adjusted and converted into a restricted stock unit award with respect to Issuer Ordinary Shares (each, an "Issuer RSU Award"), based on (I) the number of Aptiv Ordinary Shares underlying the Aptiv RSU Award immediately prior to the Distribution and (II) a fraction, the numerator of which is (A) the closing price of an Aptiv Ordinary Share on the New York Stock Exchange ("NYSE") on the trading day immediately after the Distribution Date, and (B) the denominator of which is the two-day volume-weighted average price of an Issuer Ordinary Share on the NYSE during the first and second trading days immediately after the Distribution (the "Award Conversion"). F3 · shares: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F3 · price: Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution. F4 · balance_after: This amount includes Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 21:24 UTC |
Aptiv PLC10% owner
|
OtherOrdinary shares, par value $0.01 per share | 70,893,660 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-26-001019 · es260758610_4-aptiv.xml · nonDerivative · entry 1 Aptiv PLC · CIK 0001521332 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: On March 12, 2025, Aptiv PLC, a Jersey public limited company ("Aptiv"), reported that it owned 1,000 shares, par value $0.01 per share, of Versigent Limited, which at the time constituted all of the issued and outstanding ordinary shares of Versigent Limited. On April 1, 2026, Versigent Limited converted from a limited company to a public limited company and changed its name to Versigent PLC. F3 · kind: The record date for the distribution by Aptiv of all of the ordinary shares of Versigent PLC to the holders of Aptiv ordinary shares was March 17, 2026 (the "Spin-Off"). The Spin-Off occurred before the market open on April 1, 2026. F2 · shares: Represents the outstanding ordinary shares of Versigent PLC as of April 1, 2026, which were distributed in the Spin-Off (as defined below) on April 1, 2026. F3 · price: The record date for the distribution by Aptiv of all of the ordinary shares of Versigent PLC to the holders of Aptiv ordinary shares was March 17, 2026 (the "Spin-Off"). The Spin-Off occurred before the market open on April 1, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.